This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Sylvester RJ et al. (2002) Intravesical bacillus Calmette–Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol 168: 1964–1970
Malavaud B (2004) T1G3 bladder tumours: the case for radical cystectomy. Eur Urol 45: 406–410
Amling CL et al. (1994) Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder. J Urol 151: 31–35; discussion 35–36
Malkowicz SB et al. (1990) The role of radical cystectomy in the management of high grade superficial bladder cancer (PA, P1, PIS and P2). J Urol 144: 641–645
Abdel-Latif M et al. (2004) Nodal involvement in bladder cancer cases treated with radical cystectomy: incidence and prognosis. J Urol 172: 85–89
May M et al. (2004) Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation. Urol Int 72: 103–111
Solsona E et al. (2004) The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour. BJU Int 94: 1258–1262
Acknowledgements
The synopsis was written by Chloe Harman, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Glossary
- OR (ODDS RATIO)
-
Ratio of odds of an event in intervention group to odds in control group; when <1 for an undesirable outcome, the intervention reduced the risk
- CI (CONFIDENCE INTERVAL)
-
An estimated range of values (based on a given set of sample data) that has a specified probability of containing the value being estimated
- T1G3 TUMORS
-
Superficial bladder tumors with disease confined to the subepithelial connective tissue (T1); cells are poorly differentiated (G3)
- BACILLUS CALMETTE–GUÉRIN (BCG)
-
A live attenuated strain of Mycobacterium tuberculosis that stimulates an immune response against cancer cells within the bladder
Rights and permissions
About this article
Cite this article
Abdel-Latif, M. Which clinical variables are associated with lymph node metastases in patients with superficial bladder cancer?. Nat Rev Urol 2, 214–215 (2005). https://doi.org/10.1038/ncpuro0185
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpuro0185